Nimetazepam: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A benzodiazepine derivative used as a hypnotic agent}} | |||
[[File:Nimetazepam.svg|Chemical structure of Nimetazepam|thumb|right]] | |||
'''Nimetazepam''' is a [[benzodiazepine]] derivative that is primarily used as a [[hypnotic]] agent. It is known for its sedative and anxiolytic properties, making it effective in the treatment of severe [[insomnia]] and anxiety disorders. Nimetazepam is marketed under various brand names, including Erimin. | |||
==Pharmacology== | ==Pharmacology== | ||
Nimetazepam | Nimetazepam acts on the [[central nervous system]] by enhancing the effect of the neurotransmitter [[gamma-aminobutyric acid]] (GABA) at the [[GABA_A receptor]]. This action results in increased neuronal inhibition, leading to its sedative and anxiolytic effects. The drug has a rapid onset of action and a relatively long half-life, which contributes to its effectiveness as a hypnotic. | ||
==Medical Uses== | |||
Nimetazepam is primarily prescribed for the short-term management of severe insomnia. It is also used in the treatment of anxiety disorders, where it helps to alleviate symptoms of anxiety and tension. Due to its potency and potential for dependence, it is generally recommended for use only when other treatments have failed. | |||
==Side Effects== | ==Side Effects== | ||
Common side effects of Nimetazepam include drowsiness, dizziness, and impaired coordination. More serious side effects can include [[respiratory depression]], [[hypotension]], and [[amnesia]]. Long-term use can lead to [[tolerance]], [[dependence]], and withdrawal symptoms upon discontinuation. | |||
==Legal Status== | ==Legal Status== | ||
Nimetazepam is a controlled substance in many countries due to its potential for abuse and | Nimetazepam is classified as a controlled substance in many countries due to its potential for abuse and dependence. Its legal status varies, with some countries restricting its use to prescription-only, while others have banned it entirely. | ||
== | ==Chemistry== | ||
[[File:Nimetazepam_ball-and-stick_model.png|Ball-and-stick model of Nimetazepam|thumb|left]] | |||
Nimetazepam is chemically related to other benzodiazepines, sharing a similar core structure. It is a nitrobenzodiazepine, characterized by the presence of a nitro group at the 7-position of the benzodiazepine ring. This structural feature is thought to contribute to its pharmacological activity. | |||
==Related Pages== | |||
* [[Benzodiazepine]] | * [[Benzodiazepine]] | ||
* [[Hypnotic]] | |||
* [[Anxiolytic]] | |||
* [[Insomnia]] | * [[Insomnia]] | ||
* [[ | * [[Gamma-aminobutyric acid]] | ||
[[Category:Benzodiazepines]] | [[Category:Benzodiazepines]] | ||
[[Category:Hypnotics]] | [[Category:Hypnotics]] | ||
[[Category: | [[Category:Anxiolytics]] | ||
Latest revision as of 11:41, 23 March 2025
A benzodiazepine derivative used as a hypnotic agent

Nimetazepam is a benzodiazepine derivative that is primarily used as a hypnotic agent. It is known for its sedative and anxiolytic properties, making it effective in the treatment of severe insomnia and anxiety disorders. Nimetazepam is marketed under various brand names, including Erimin.
Pharmacology[edit]
Nimetazepam acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased neuronal inhibition, leading to its sedative and anxiolytic effects. The drug has a rapid onset of action and a relatively long half-life, which contributes to its effectiveness as a hypnotic.
Medical Uses[edit]
Nimetazepam is primarily prescribed for the short-term management of severe insomnia. It is also used in the treatment of anxiety disorders, where it helps to alleviate symptoms of anxiety and tension. Due to its potency and potential for dependence, it is generally recommended for use only when other treatments have failed.
Side Effects[edit]
Common side effects of Nimetazepam include drowsiness, dizziness, and impaired coordination. More serious side effects can include respiratory depression, hypotension, and amnesia. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Legal Status[edit]
Nimetazepam is classified as a controlled substance in many countries due to its potential for abuse and dependence. Its legal status varies, with some countries restricting its use to prescription-only, while others have banned it entirely.
Chemistry[edit]

Nimetazepam is chemically related to other benzodiazepines, sharing a similar core structure. It is a nitrobenzodiazepine, characterized by the presence of a nitro group at the 7-position of the benzodiazepine ring. This structural feature is thought to contribute to its pharmacological activity.